Minnesota RETAIN Phase 3
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
MN RETAIN Phase 3 is a non-randomized trial to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Education (DOE). There will be collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay-at-work and return-to-work. MN RETAIN involves a partnership between Mayo Clinic and MN Department of Employment and Economic Development (DEED), and stakeholders throughout MN. MN DEED serves as the main recipient and administrator of the funding within the state with Mayo Clinic a subrecipients of the grant.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
> 18-years-old,
MN Resident,
Works or intends to work in MN,
Employed at the time of enrollment (must be a W2 employee) OR,
Disqualifiers
Does not have the capacity to give appropriate informed consent,
Active workers' compensation claim relating to the qualifying injury or illness,
Pending application OR Receiving Social Security Disability Insurance (SSDI) or -Supplemental Security Income (SSI),
Self-Employed (i.e., 1099 worker)
Trial design
Design model
Single group
Treatments tested in this trial
RETAIN Program
Other interventionFacilitates early intervention strategies to support workers in staying-at or returning-to-work (SAW/RTW) after injury or illness and preventing unnecessary disability. This is done by incorporating a Return-to-Work Case Manager as a member of the healthcare clinical team who acts as a liaison for the patient and assists in coordination of referrals between healthcare and Workforce Development services. Return-to-Work Case Managers will interact with treating providers of Minnesota RETAIN participants to ensure functionally based work restrictions are documented and shared with the patient's employer.
Treatment groups
1,000 Participants
are divided into 1 treatment groupGroup A: Phase 3Experimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Workers to maintain employment
Of the individuals participating, the number who achieve or maintain competitive integrated employment at the end of the enrollment period.
Time frame
6 month after enrollmentSecondary outcomes
1
Engagement Statewide
Percentage of participants living in individual MN counties with a goal of at least 50% of counties.
Time frame
3 yearsOther outcomes
1
Accessibility for individuals with disabilities acutely impacting work based
Total number of categories of disabilities based on workforce innovation act categories
Time frame
4 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Mayo Clinic
Lead sponsor
Minnesota Department of Employment and Economic Development
Collaborator
U.S. Department of Education
Collaborator
Source ClinicalTrials.gov